Humacyte (HUMA) Change in Cash (2020 - 2026)

Humacyte (HUMA) has 7 years of Change in Cash data on file, last reported at -$2.0 million in Q1 2026.

• Change in Cash for Q1 2026 came in at -$2.0 million, down 110.93% year-over-year; the trailing twelve-month figure through Mar 2026 was -$64.3 million (down 2319.41% YoY), and the FY2025 annual result was -$44.4 million, down 406.72% from the prior year.
• Change in Cash slipped to -$2.0 million in Q1 2026 per HUMA's latest filing, from $31.0 million in the prior quarter.
• Over five years, Change in Cash peaked at $35.1 million in Q1 2024 and troughed at -$68.5 million in Q3 2025.
• A 5-year average of -$9.9 million and a median of -$17.2 million in 2022 frame the typical range for Change in Cash.
• The sharpest annual moves came in 2022 and 2024: Change in Cash slumped 510.3% in 2022, then jumped 273.53% in 2024.
• A 5-year view of Change in Cash shows it stood at -$14.0 million in 2022, then tumbled by 39.97% to -$19.5 million in 2023, then jumped by 224.7% to $24.4 million in 2024, then rose by 27.26% to $31.0 million in 2025, then sank by 106.31% to -$2.0 million in 2026.
• Business Quant data shows HUMA's Change in Cash at -$2.0 million in Q1 2026, $31.0 million in Q4 2025, and -$68.5 million in Q3 2025.